X0203 3 2010-04-21 0 0001267602 ALIMERA SCIENCES INC ALIM 0001277997 VENROCK ASSOCIATES IV L P C/O VENROCK 3340 HILLVIEW AVENUE PALO ALTO CA 94304 0 0 1 0 0001305238 Venrock Management IV, LLC C/O VENROCK 3340 HILLVIEW AVENUE PALO ALTO CA 94304 0 0 1 0 0001305239 Venrock Partners, L.P. C/O VENROCK 3340 HILLVIEW AVENUE PALO ALTO CA 94304 0 0 1 0 0001305240 Venrock Partners Management, LLC C/O VENROCK 3340 HILLVIEW AVENUE PALO ALTO CA 94304 0 0 1 0 0001277994 VENROCK ENTREPRENEURS FUND IV L P C/O VENROCK 3340 HILLVIEW AVENUE PALO ALTO CA 94304 0 0 1 0 0001305243 VEF Management IV, LLC C/O VENROCK 3340 HILLVIEW AVENUE PALO ALTO CA 94304 0 0 1 0 Series B Convertible Preferred Stock Common Stock 2243732 I By Funds Series C Convertible Preferred Stock Common Stock 934110 I By Funds Series C-1 Convertible Preferred Stock Common Stock 465157 I By Funds The convertible preferred stock is convertible at any time, at the holder's election, on a one-for-one basis and has no expiration date. The number of shares reflects the 3.4-for-1 reverse stock split of the Issuer's common stock and convertible preferred stock effective prior to the Issuer's initial public offering. Consists of 1,826,398 shares of the Issuer's Series B Convertible Preferred Stock ("Series B Shares") held by Venrock Associates IV, L.P. ("VA4"), 372,460 Series B Shares held by Venrock Partners, L.P. ("VP") and 44,874 Series B Shares held by Venrock Entrepreneurs Fund IV, L.P. ("VEF4"). Venrock Management IV, LLC ("VM4"), Venrock Partners Management, LLC ("VPM") and VEF Management IV, LLC ("VEFM4") are the sole general partners of VA4, VP and VEF4, respectively. Anders D. Hove, a director of the Issuer, is a member of VM4, VPM and VEFM4. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP and VEF4, except to the extent of his indirect pecuniary interest therein. VM4, VPM and VEFM4 expressly disclaim beneficial ownership over all shares held by VA4, VP and VEF4, except to the extent of their indirect pecuniary interest therein. Consists of 760,367 shares of the Issuer's Series C Convertible Preferred Stock ("Series C Shares") held by VA4, 155,062 Series C Shares held by VP and 18,681 Series C Shares held by VEF4. VM4, VPM and VEFM4 are the sole general partners of VA4, VP and VEF4, respectively. Dr. Hove is a member of VM4, VPM and VEFM4. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP and VEF4, except to the extent of his indirect pecuniary interest therein. VM4, VPM and VEFM4 expressly disclaim beneficial ownership over all shares held by VA4, VP and VEF4, except to the extent of their indirect pecuniary interest therein. Consists of 378,639 shares of the Issuer's Series C-1 Convertible Preferred Stock ("Series C-1 Shares") held by VA4, 77,215 Series C-1 Shares held by VP and 9,303 Series C-1 Shares held by VEF4. VM4, VPM and VEFM4 are the sole general partners of VA4, VP and VEF4, respectively. Dr. Hove is a member of VM4, VPM and VEFM4. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP and VEF4, except to the extent of his indirect pecuniary interest therein. VM4, VPM and VEFM4 expressly disclaim beneficial ownership over all shares held by VA4, VP and VEF4, except to the extent of their indirect pecuniary interest therein. /s/ David L. Stepp, Authorized Signatory 2010-04-21 /s/ David L. Stepp, Authorized Signatory 2010-04-21 /s/ David L. Stepp, Authorized Signatory 2010-04-21 /s/ David L. Stepp, Authorized Signatory 2010-04-21 /s/ David L. Stepp, Authorized Signatory 2010-04-21 /s/ David L. Stepp, Authorized Signatory 2010-04-21